rss
Ann Rheum Dis 2006;65:394-397 doi:10.1136/ard.2005.038042
  • Concise report

Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjögren’s syndrome

  1. D Sène1,
  2. P Ghillani-Dalbin2,
  3. N Limal1,
  4. V Thibault3,
  5. T van Boekel4,
  6. J-C Piette1,
  7. P Cacoub1
  1. 1Department of Internal Medicine, Hôpital La Pitié-Salpêtrière, Paris, France
  2. 2Department of Immunochemistry, Hôpital La Pitié-Salpêtrière
  3. 3Department of Virology, Hôpital La Pitié-Salpêtrière
  4. 4Research and Development, Euro Diagnostica BV, Harnhem, Netherlands
  1. Correspondence to:
    Professor Patrice Cacoub
    Department of Internal Medicine, Hôpital La Pitié-Salpêtrière, 83 Boulevard de l’Hôpital, 75651 Paris Cedex 13, France; patrice.cacoub{at}psl.ap-hop-paris.fr
  • Accepted 11 July 2005

Abstract

Objective: To investigate the diagnostic reliability of anti-CCP antibodies (anti-CCP Ab) in distinguishing hepatitis C virus (HCV) associated rheumatological manifestations and Sjögren’s syndrome from rheumatoid arthritis.

Methods: 147 HCV infected patients (HCV RNA positive) were compared with 64 patients with definite rheumatoid arthritis in a retrospective study. Anti-CCP Ab were detected using the Immunoscan ELISA kit (second generation) and rheumatoid factor (RF) by the FIDIS™ Rheuma kit.

Results: Among the 147 HCV infected patients (77 women; mean (SD) age 58 (16) years), 77 (52%) had a mixed cryoglobulin (MC), 38 (26%) an MC associated systemic vasculitis, 35 (24%) arthralgia/arthritis, and seven (5%) definite Sjögren’s syndrome. HCV infected patients with arthralgia were more often RF positive than those without arthralgia (54% v 27%; p = 0.003), but less often than patients with rheumatoid arthritis (54% v 81%; p = 0.009). Anti-CCP Ab were detected in only two HCV infected patients with arthralgia (5.7%), in none without arthralgia or with Sjögren’s syndrome, and in 78% of patients with rheumatoid arthritis. With a specificity of 93.5% and a positive predictive value of 96% for rheumatoid arthritis, anti-CCP Ab were the most specific biological marker.

Conclusions: Anti-CCP antibodies are very rarely found in HCV infected patients with rheumatological manifestations or Sjögren’s syndrome. They are reliable serological markers to distinguish these from patients with rheumatoid arthritis.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.